Spectral AI's Upcoming Presentation on Burn Wound Assessment
Spectral AI to Present Findings at BBA / ISBI Joint Conference
DALLAS, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), a leader in artificial intelligence (AI) technology tailored for medical diagnostics, has shared that Dr. Jeffrey Carter will present pivotal data from a comprehensive multicenter study. This study focuses on the application of Spectral AI’s groundbreaking DeepView™ System, which employs non-invasive multispectral imaging combined with proprietary AI algorithms to identify areas of non-healing within thermal (burn) injuries.
Dr. Carter serves as the Medical Director of the Burn Center at a prominent university medical facility and is also a Professor of Surgery at a respected health institution. He is currently the Chief Medical Consultant for Spectral AI.
Highlighting the scarcity of burn treatment resources in the U.S., Dr. Carter points out that there are only around 130 burn centers available, leading to a limited number of beds and a notable decline in the training of burn surgeons. These limitations would be exacerbated in an emergency scenario, potentially leading to misdiagnoses and a diminished standard of care for patients.
Notably, the DeepView™ System has demonstrated a superior ability to accurately assess burn depth, performing better than even experienced clinicians. This strengthens the Company’s assertion that utilizing a high-performing, AI-driven model alongside clinician assessments will significantly enhance the treatment speed and outcomes for patients presenting with acute burn injuries.
“Our healthcare system’s structural limitations in treating burn victims, coupled with the complexity of such injuries, poses substantial challenges for healthcare providers, patients, and medical institutions,” stated Dr. Carter. “We believe that the DeepView™ System can bridge these care gaps by supplying timely and precise assessments of burn wounds, which surpass the capabilities of even the most experienced burn physicians. This predictive technology stands to offer considerable benefits in daily healthcare operations as well as during mass casualty events.”
Details of the Upcoming Presentation
Presenter: Jeffrey E. Carter, MD, FACS
Title: Burn Severity Assessment Using Multispectral Imaging and AI: Analysis of a Multicenter Study
Day: Wednesday, August 21
Time: 15:30-17:00 BST
Location: International Conference Centre (ICC) Hall 11B, Birmingham, UK
The Company’s ongoing U.S. Burn Pivotal Study aims to validate the AI-driven algorithm employed by the DeepView™ System for burn severity assessment. This will be the final clinical trial prior to seeking FDA approval for the DeepView™ System’s indication in 2025.
About Spectral AI
Spectral AI, Inc., based in Dallas, is dedicated to revolutionizing medical diagnostics through predictive AI, particularly in wound care management. The initial focus is on treating patients suffering from burns and diabetic foot ulcers. The Company enhances patient care by “Seeing the Unknown” with its innovative DeepView™ System, a predictive device providing clinicians with objective and immediate assessments of wound healing potential before any medical intervention. By utilizing algorithm-driven insights, the DeepView™ System aims to transform the standard of care, yielding faster, more precise treatment recommendations that improve patient outcomes while reducing overall healthcare costs.
Frequently Asked Questions
1. What is Spectral AI's DeepView™ System?
The DeepView™ System is an advanced predictive device that leverages multispectral imaging and AI to assess the healing potential of wounds, particularly in burn patients.
2. Who will be presenting at the upcoming conference?
Dr. Jeffrey Carter, Medical Director of the Burn Center and Chief Medical Consultant at Spectral AI, will be presenting findings from their multicenter study.
3. Where will the presentation take place?
The presentation is scheduled to occur at the International Conference Centre (ICC) Hall 11B, Birmingham, UK.
4. Why is the DeepView™ System significant?
The DeepView™ System significantly enhances the accuracy of burn depth assessments, improving outcomes by potentially identifying non-healing areas faster than traditional methods.
5. What are the next steps for Spectral AI regarding FDA approval?
The Company is conducting an ongoing pivotal study to validate its AI-driven algorithm, with plans to seek FDA approval for the DeepView™ System in 2025.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/